Afatinib Dimaleate from Japan

Afatinib dimaleate is an irreversible EGFR inhibitor for non-small cell lung cancer. As a quinazoline-based aromatic nitrogen heterocycle drug, it falls under HTS 2933.99.75.00.

Duty Rate — Japan → United States

6.5%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

,FDA prior notice required 72 hours before arrival for drug substances

Use ISF importer security filing for ocean shipments of pharma APIs